Filing Flows › Ironwood Pharmaceuticals (IRWD) › Who owns the stock
Who owns Ironwood Pharmaceuticals (IRWD) stock
198 funds reported Ironwood Pharmaceuticals (IRWD) shares in their latest 13F filings, worth $714M in all. The largest holder is BlackRock ($74.9M). Last quarter 88 funds added to their stakes and 113 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 17,788,557 | $74.9M | increase | 2026-06-30 |
| Armistice Capital, LLC | 13,932,000 | $58.7M | decrease | 2026-06-30 |
| Vanguard Group | 15,958,196 | $53.8M | decrease | 2025-12-31 |
| Sarissa Capital Management LP | 9,188,635 | $38.7M | unchanged | 2026-06-30 |
| State Street | 8,809,601 | $37.1M | increase | 2026-06-30 |
| Bank of America | 8,683,803 | $36.6M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 7,993,226 | $33.7M | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 6,608,508 | $27.8M | increase | 2026-06-30 |
| AQR Capital Management LLC | 6,465,921 | $27.2M | decrease | 2026-06-30 |
| Acadian Asset Management LLC | 5,853,331 | $24.6M | decrease | 2026-06-30 |
| Vanguard Portfolio Management LLC | 5,513,355 | $23.2M | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 4,831,657 | $20.3M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 4,556,089 | $19.2M | decrease | 2026-06-30 |
| Marshall Wace, LLP | 4,290,093 | $18.1M | decrease | 2026-06-30 |
| Jacobs Levy Equity Management | 4,065,964 | $17.1M | increase | 2026-06-30 |
Ironwood Pharmaceuticals' latest quarter
Ironwood Pharmaceuticals, Q3 2026: revenue $133M (+9% year over year), operating margin 70.0%, net earnings $59.8M, operating cash flow $67.4M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most IRWD stock?
By the latest 13F filings: BlackRock ($74.9M); Armistice Capital, LLC ($58.7M); Vanguard Group ($53.8M); Sarissa Capital Management LP ($38.7M); State Street ($37.1M).
What is the short interest in IRWD?
15,887,553 shares were sold short at the 2026-10-15 settlement, 2.05% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.